Publish date: Mar 29, 2023
true
I am delighted to share our latest publication on the future of diagnostic services.
Click here to download the executive summary.
Focused on the action that Integrated Care Boards can take to increase the quality and access of testing to deliver for patients, I am looking forward to discussing its recommendations with our partners.
Millions of diagnostic tests take place in the NHS each week helping to diagnose patients and identify the next steps in their treatment journey. And yet there are still patients who cannot access the tests that they need and innovations such as digital pathology, greater use of machine learning and AI, and at-home testing are not being adopted widely across the NHS. ICBs are well placed to take a more holistic view across some of the traditional boundaries between services and identify how doing things differently can benefit patients and the system.
We want to work in partnership with the NHS to make sure patients can access the tests they need, when they need them and get accurate results quickly and easily. To help, we have identified a series of recommendations for action at regional and local level covering:
- Identifying the value of diagnostic services
- Putting patients at the centre of diagnostics
- Making better use of existing resources
- Focusing on decision-making and procurement.
Learn more and get a copy of the full white paper here
Bruce Caldwell
Country Business Leader, Integrated Diagnostic Solutions
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 75,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.
true
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 75,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.
true
true
